CD79A and inflammatory bowel disease: In this study, Ig-seq was performed on the stool of patients with IBD and those with IBD who received FMT, and it was found that compared with healthy people, fecal IgA/G-binding bacteria in the patients with UC and CD are expected to be potential biomarkers for evaluating disease activity.